- Higher-dose radiotherapy (RT) is associated with improved locoregional PFS (LPFS) and OS of patients with anaplastic thyroid cancer (ATC).
Why this matters
- This study may help guide treatment of patients with this aggressive form of thyroid cancer.
- 1-year LPFS was 74.4%; 1-year OS was 34.4%.
- RT ≥60 Gy was associated with improved LPFS (87.2% vs 55.3%; HR, 0.135; P=.001) and OS (47.9% vs 17.4%; HR, 0.487; P=.004) compared with RT dose
- Trimodal therapy (surgical resection, chemotherapy, and RT with dose ≥60 Gy) was associated with improved LPFS (85.9% vs 54.1%; HR, 0.060; P=.017) compared with other treatment regimens.
- Grade 3 dermatitis was experienced by 20% of patients and grade 3 mucositis was experienced by 13% of patients.
- 104 patients with ATC, 29.8% with metastatic disease, who received curative-intent or postoperative RT were included.
- Funding: NIH/NCI, Marie-Josée and Henry R. Kravis Center for Molecular Oncology.
- Retrospective study.